Welcome to our dedicated page for Callan JMB news (Ticker: CJMB), a resource for investors and traders seeking the latest updates and insights on Callan JMB stock.
Callan JMB Inc. (CJMB) delivers specialized cryogenic logistics solutions for life sciences organizations requiring precision temperature control. This news hub provides investors and industry professionals with essential updates about the company's operational developments and market position.
Access timely announcements including regulatory milestones, technology innovations, and strategic partnerships. Our curated collection helps stakeholders track CJMB's progress in revolutionizing cold chain logistics through sustainable practices and predictive monitoring systems.
Discover official statements regarding:
• New cold chain technology deployments
• Pharmaceutical logistics partnerships
• Environmental compliance achievements
• Supply chain optimization initiatives
Bookmark this page for verified updates about CJMB's role in maintaining product integrity for vaccines, biologics, and temperature-sensitive medical therapies. Check regularly for insights into how the company addresses evolving challenges in life sciences logistics.
Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics company, has announced its participation in Maxim Group's 2025 Virtual Tech Conference. The company will engage in a fireside chat on June 3, 2025, at 10:30 a.m. ET. The conference, themed "Discover the Innovations Reshaping Tomorrow," will run from June 3-5, 2025.
Callan JMB specializes in fulfillment, storage, monitoring, and cold chain logistics services for the healthcare industry and emergency management agencies. Interested parties can register through the provided link or contact KCSA Strategic Communications for meetings.
Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics company, reported its Q1 2025 financial results following its February IPO. The company raised $5.7 million through its IPO at $4.00 per share. Q1 2025 financial results showed revenue of $1.45 million, with a gross profit margin of 42.5%, but reported a net loss of $1.2 million due to increased SG&A expenses and declining emergency preparedness service demand.
Key developments include appointing Christopher Shields as SVP of Emergency Preparedness & Response, renewing contracts with Texas DSHS, securing a five-year contract with Oregon Health Authority, and launching a vaccine management lease program. The company is expanding into GLP-1 pharmaceutical transportation, specialized compounding pharmacy logistics, and premium food packaging services.
Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics services provider, has announced its upcoming participation in the Aegis Capital Corp. Virtual Conference scheduled for May 21, 2025. The company's management team will deliver a presentation at 1:00 p.m. ET. Callan JMB specializes in fulfillment, storage, monitoring, and cold chain logistics services for the healthcare industry and emergency management agencies.
Callan JMB (NASDAQ: CJMB) has appointed Christopher Shields as Senior Vice President of Emergency Preparedness & Response/Government Affairs. Shields, former Assistant Commissioner of the Chicago Department of Public Health, brings over 14 years of experience managing the city's Emergency Preparedness and Bioterrorism program.
In his previous role, Shields managed the Tier 1 Medical Pharmacy operations, advanced vaccine inventory systems, and led critical functions including Continuity of Operations and Emergency Operations Planning. His extensive experience includes responding to major events such as 9/11, Hurricane Katrina, H1N1 Pandemic, and the COVID-19 crisis.
CEO Wayne Williams highlighted that Shields' appointment will help Callan JMB expand its emergency preparedness and response operations into new cities and states. The company currently provides integrative logistics services for healthcare industry and emergency management agencies, including fulfillment, storage, monitoring, and cold chain logistics services.
Callan JMB (NASDAQ: CJMB), a company specializing in integrative logistics for healthcare and emergency management agencies, has announced its participation in the upcoming LD Micro Invitational Conference in New York City.
The event will take place at the Westin Grand Central on April 9-10, 2025. The company's management team is scheduled to present on Thursday, April 10th at 3:30 p.m. ET in Track 3. The presentation will be accessible via webcast through the LD Micro platform.
Additionally, the management team will be available for one-on-one investor meetings during the conference, which can be arranged through LD Micro representatives or KCSA Strategic Communications.
Callan JMB (NASDAQ: CJMB), a logistics company specializing in healthcare and emergency management, reported its full year 2024 financial results. The company successfully completed its IPO on February 6, 2025, raising approximately $5.7 million at $4.00 per share.
Key financial metrics for 2024 include:
- Total revenue: $6.6 million ($3.8M from emergency response, $2.8M from specialty packaging)
- Gross profit: $2.6 million with 39.1% margin
- Operating loss: $2.3 million
- Net loss: $2.3 million
Notable achievements include extending arrangements with Texas DSHS, securing a five-year contract with Oregon Health Authority, launching a vaccine management lease program, and joining Complete Group Services. Revenue was impacted by reduced emergency preparedness services post-COVID and a temporary suspension of orders from one customer.
Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics services provider, has announced its participation in two major investor conferences in March 2025.
The company will present at the Sidoti Spring Small-Cap Conference (March 19-20, virtual) with CEO Wayne Williams speaking on March 19th at 10:45 a.m. ET. Additionally, they will participate in the iAcccess Alpha Virtual Best Ideas Spring Investment Conference (March 25-26) with a presentation on March 25th at 10:30 a.m. ET.
Management will conduct one-on-one investor meetings during both conferences. Interested parties can schedule meetings through Sidoti or iAccess Alpha representatives, or by contacting KCSA Strategic Communications.
Callan JMB (NASDAQ: CJMB) has been requested by the Texas Department of Health and Human Services to be on standby for the recent measles outbreak response. The company holds a five-year contingency contract awarded in 2023 for receiving, storing, and distributing medical countermeasures for public health emergencies.
The company is proactively submitting a 30-day roster of 24/7 available personnel to handle distribution requests. This follows their successful track record from their first emergency response contract in 2018, which was activated during the COVID-19 and MPOX pandemic, where they managed the storage and distribution of over 2 million vaccines and therapeutics.
The current measles outbreak has claimed one life, and Callan JMB is preparing to support the state's emergency response with their expert staff, equipped facilities, and quality-controlled inventory management system.